BFH vs SFNC

BFH exhibits a mixed financial profile with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score limits distress risk assessment. The stock appears undervalued with a P/E of 7.19 versus sector average of 21.34 and trades below both the Graham Number ($124.61) and intrinsic value estimate ($282.31), suggesting significant upside potential. Strong earnings growth (YoY EPS +118.5%, Earnings Growth YoY 9703.90%) and consistent analyst target support ($80.07) contrast with deteriorating technical trend (0/100) and lack of insider activity. Key risks include incomplete financial data (missing debt, cash, EV metrics), volatile earnings surprises, and declining short-term price momentum.

The deterministic health baseline is critical, with a Piotroski F-Score of 1/9 indicating severe financial deterioration. Despite a recent price rally and strong YoY earnings growth, the company is reporting negative ROE (-10.37%) and ROA (-1.40%), suggesting fundamental instability. The stock trades at a discount to book value (P/B 0.91), which is a typical market reaction to the poor health metrics. The disconnect between the bullish analyst consensus and the failing deterministic scores suggests a high-risk profile.